Brunel Medical Services Limited - Period Ending 2021-04-30

Brunel Medical Services Limited - Period Ending 2021-04-30


Brunel Medical Services Limited 07351791 false 2020-05-01 2021-04-30 2021-04-30 The principal activity of the company is that of the provision of medical services. Digita Accounts Production Advanced 6.29.9459.0 true true 07351791 2020-05-01 2021-04-30 07351791 2021-04-30 07351791 bus:OrdinaryShareClass1 2021-04-30 07351791 bus:OrdinaryShareClass2 2021-04-30 07351791 bus:OrdinaryShareClass3 2021-04-30 07351791 bus:OrdinaryShareClass4 2021-04-30 07351791 bus:OrdinaryShareClass5 2021-04-30 07351791 bus:OtherShareClass1 2021-04-30 07351791 bus:OtherShareClass2 2021-04-30 07351791 core:CurrentFinancialInstruments 2021-04-30 07351791 core:CurrentFinancialInstruments core:WithinOneYear 2021-04-30 07351791 core:FurnitureFittingsToolsEquipment 2021-04-30 07351791 core:LandBuildings 2021-04-30 07351791 core:OtherRelatedParties 2021-04-30 07351791 bus:SmallEntities 2020-05-01 2021-04-30 07351791 bus:AuditExemptWithAccountantsReport 2020-05-01 2021-04-30 07351791 bus:FullAccounts 2020-05-01 2021-04-30 07351791 bus:SmallCompaniesRegimeForAccounts 2020-05-01 2021-04-30 07351791 bus:RegisteredOffice 2020-05-01 2021-04-30 07351791 bus:Director2 2020-05-01 2021-04-30 07351791 bus:Director3 2020-05-01 2021-04-30 07351791 bus:Director5 2020-05-01 2021-04-30 07351791 bus:OrdinaryShareClass1 2020-05-01 2021-04-30 07351791 bus:OrdinaryShareClass2 2020-05-01 2021-04-30 07351791 bus:OrdinaryShareClass3 2020-05-01 2021-04-30 07351791 bus:OrdinaryShareClass4 2020-05-01 2021-04-30 07351791 bus:OrdinaryShareClass5 2020-05-01 2021-04-30 07351791 bus:OtherShareClass1 2020-05-01 2021-04-30 07351791 bus:OtherShareClass2 2020-05-01 2021-04-30 07351791 bus:PrivateLimitedCompanyLtd 2020-05-01 2021-04-30 07351791 core:FurnitureFittingsToolsEquipment 2020-05-01 2021-04-30 07351791 core:LandBuildings 2020-05-01 2021-04-30 07351791 core:OtherRelatedParties 2020-05-01 2021-04-30 07351791 countries:AllCountries 2020-05-01 2021-04-30 07351791 2020-04-30 07351791 core:FurnitureFittingsToolsEquipment 2020-04-30 07351791 core:LandBuildings 2020-04-30 07351791 2019-05-01 2020-04-30 07351791 2020-04-30 07351791 bus:OrdinaryShareClass1 2020-04-30 07351791 bus:OrdinaryShareClass2 2020-04-30 07351791 bus:OrdinaryShareClass3 2020-04-30 07351791 bus:OrdinaryShareClass4 2020-04-30 07351791 bus:OrdinaryShareClass5 2020-04-30 07351791 bus:OtherShareClass1 2020-04-30 07351791 bus:OtherShareClass2 2020-04-30 07351791 core:CurrentFinancialInstruments 2020-04-30 07351791 core:CurrentFinancialInstruments core:WithinOneYear 2020-04-30 07351791 core:FurnitureFittingsToolsEquipment 2020-04-30 07351791 core:LandBuildings 2020-04-30 07351791 core:OtherRelatedParties 2020-04-30 iso4217:GBP xbrli:pure xbrli:shares

Brunel Medical Services Limited

Annual Report and Unaudited Financial Statements
Year Ended 30 April 2021

Registration number: 07351791

 

Brunel Medical Services Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 9

 

Brunel Medical Services Limited

Company Information

Directors

Dr A S Vian

Dr S K Bowler

Dr R Veale

Registered office

Centenary House
Peninsula Park
Rydon Lane
Exeter
EX2 7XE

Accountants

PKF Francis Clark LLP
Centenary House
Peninsula Park
Rydon Lane
Exeter
EX2 7XE

 

Brunel Medical Services Limited

Balance Sheet

30 April 2021

Note

2021
£

2020
£

Fixed assets

 

Tangible assets

4

786,886

737,160

Current assets

 

Debtors

5

59,114

63,202

Cash at bank and in hand

 

1,026

1,179

 

60,140

64,381

Creditors: Amounts falling due within one year

6

(27,002)

(50,162)

Net current assets

 

33,138

14,219

Total assets less current liabilities

 

820,024

751,379

Provisions for liabilities

(1,900)

(1,700)

Net assets

 

818,124

749,679

Capital and reserves

 

Called up share capital

9,999

9,999

Revaluation reserve

106,941

56,941

Profit and loss account

701,184

682,739

Shareholders' funds

 

818,124

749,679

 

Brunel Medical Services Limited

Balance Sheet

30 April 2021

For the financial year ending 30 April 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 15 November 2021 and signed on its behalf by:
 

.........................................
Dr R Veale
Director

   
     

Company Registration Number: 07351791

 

Brunel Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 April 2021

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Centenary House
Peninsula Park
Rydon Lane
Exeter
EX2 7XE

These financial statements were authorised for issue by the Board on 15 November 2021.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', including Section 1A and the Companies Act 2006. There are no material departures from FRS 102.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

COVID-19

The directors of Brunel Medical Services Limited have considered the impact of COVID-19.

In the opinion of the directors, the company has sufficient working capital within existing facilities to continue to trade for the foreseeable future, and therefore the financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover represents amounts receivable for the provision of medical and management services.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 

Brunel Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 April 2021

Contract revenue recognition

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated relaibly, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Tax

Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on all timing differences at the balance sheet date unless indicated below. Timing differences are differences between taxable profits and the results as stated in the profit and loss account and other comprehensive income. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Freehold land and buildings

Not depreciated

Fixtures, fittings and equipment

25% per annum on a reducing balance basis

 

Brunel Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 April 2021

Financial instruments

Classification
The company holds the following financial instruments:

• Short term trade and other debtors and creditors;
• Cash and bank balances.

All financial instruments are classified as basic.

 Recognition and measurement
The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

Such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.


 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2020 - 5).

 

Brunel Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 April 2021

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 May 2020

720,000

65,867

785,867

Revaluations

50,000

-

50,000

Additions

-

4,664

4,664

At 30 April 2021

770,000

70,531

840,531

Depreciation

At 1 May 2020

-

48,707

48,707

Charge for the year

-

4,938

4,938

At 30 April 2021

-

53,645

53,645

Carrying amount

At 30 April 2021

770,000

16,886

786,886

At 30 April 2020

720,000

17,160

737,160

Included within the net book value of land and buildings above is £770,000 (2020 - £720,000) in respect of freehold land and buildings.
 

5

Debtors

2021
£

2020
£

Trade debtors

1,314

3,254

Other debtors

57,800

59,948

59,114

63,202

 

Brunel Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 April 2021

6

Creditors

Creditors: amounts falling due within one year

2021
£

2020
£

Due within one year

Trade creditors

-

458

Taxation and social security

18,000

22,000

Accruals and deferred income

3,002

4,204

Other creditors

6,000

23,500

27,002

50,162

7

Share capital

Allotted, called up and fully paid shares

 

2021

2020

 

No.

£

No.

£

Ordinary B shares of £1 each

2,352

2,352

2,352

2,352

Ordinary E shares of £1 each

1,765

1,765

1,765

1,765

Ordinary F shares of £1 each

1,765

1,765

1,765

1,765

Ordinary H shares of £0 each

-

-

-

-

Ordinary I shares of £1 each

1,765

1,765

1,765

1,765

Ordinary J shares of £1 each

2,352

2,352

2,352

2,352

Ordinary K shares of £0 each

-

-

-

-

 

9,999

9,999

9,999

9,999

During the year the 1,304 ordinary H shares were redesignated to other share classes as follows: 307 ordinary B shares, 230 ordinary E shares, 231 ordinary F shares, 230 ordinary I shares and 306 ordinary J shares.

During the year the 1,305 ordinary K shares were redesignated to other share classes as follows: 306 ordinary B shares, 231 ordinary E shares, 230 ordinary F shares, 231 ordinary I shares and 307 ordinary J shares.

Rights, preferences and restrictions

The B - K ordinary shares have the following rights, preferences and restrictions:
The B - K ordinary shares all carry the same rights and privileges and rank pari passu in all respects, except that in respect of dividends the directors shall not be bound to treat the B - K ordinary shares in the same manner.

 

Brunel Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 April 2021

8

Related party transactions

Summary of transactions with other related parties

Brunel Medical Practice
 (The directors of the company are all partners within the Brunel Medical Practice partnership)
 During the year a loan account existed between the company and the Brunel Medical Practice. The company charged the partnership £60,000 (2020: £60,000) for management services in the year. The company also made advances to the partnership in the year amounting to £50,959 (2020: £79,864). Repayments were received from the partnership during the year amounting to £113,107 (2020: £79,916). The loan between the company and the partnership is interest free and repayable on demand.
 

2021

£

Amounts receivable from related party

57,800

2020

£

Amounts receivable from related party

59,948